These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 24460667)

  • 1. Antisepsis with polyhexanide is effective against endophthalmitis after intravitreal injections.
    Ristau T; Kirchhof B; Fauser S
    Acta Ophthalmol; 2014 Sep; 92(6):e494-6. PubMed ID: 24460667
    [No Abstract]   [Full Text] [Related]  

  • 2. Endophthalmitis is not a "never event".
    Schachat AP; Rosenfeld PJ; Liesegang TJ; Stewart MW
    Ophthalmology; 2012 Aug; 119(8):1507-8. PubMed ID: 22858024
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of prophylactic topical antibiotics on bacterial resistance patterns in endophthalmitis following intravitreal injection.
    Storey P; Dollin M; Rayess N; Pitcher J; Reddy S; Vander J; Hsu J; Garg S;
    Graefes Arch Clin Exp Ophthalmol; 2016 Feb; 254(2):235-42. PubMed ID: 25940556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reducing the risk of endophthalmitis after intravitreous injection.
    Kim SJ; Chomsky AS; Sternberg P
    JAMA Ophthalmol; 2013 May; 131(5):674-5. PubMed ID: 23699844
    [No Abstract]   [Full Text] [Related]  

  • 5. Aqueous Chlorhexidine for Intravitreal Injection Antisepsis: A Case Series and Review of the Literature.
    Merani R; McPherson ZE; Luckie AP; Gilhotra JS; Runciman J; Durkin S; Muecke J; Donaldson M; Aralar A; Rao A; Davies PE
    Ophthalmology; 2016 Dec; 123(12):2588-2594. PubMed ID: 27720552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current Methods to Reduce Endophthalmitis After Intravitreal Injection.
    Kim SJ; Fine HF
    Ophthalmic Surg Lasers Imaging Retina; 2015; 46(10):996-1000. PubMed ID: 26599240
    [No Abstract]   [Full Text] [Related]  

  • 7. Meta-analysis of endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents: causative organisms and possible prevention strategies.
    McCannel CA
    Retina; 2011 Apr; 31(4):654-61. PubMed ID: 21330939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Influence of Universal Face Mask Use on Endophthalmitis Risk after Intravitreal Anti-Vascular Endothelial Growth Factor Injections.
    ; Patel SN; Tang PH; Storey PP; Wolfe JD; Fein J; Shah SP; Chen E; Abbey A; Ferrone PJ; Shah CP; Liang MC; Stem MS; Ali Khan M; Yonekawa Y; Garg SJ
    Ophthalmology; 2021 Nov; 128(11):1620-1626. PubMed ID: 34019955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Impact of Physician Face Mask Use on Endophthalmitis After Intravitreal Anti-Vascular Endothelial Growth Factor Injections.
    Patel SN; Hsu J; Sivalingam MD; Chiang A; Kaiser RS; Mehta S; Park CH; Regillo CD; Sivalingam A; Vander JF; Ho AC; Garg SJ;
    Am J Ophthalmol; 2021 Feb; 222():194-201. PubMed ID: 32888902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prophylactic antibiotic use after intravitreal injection: effect on endophthalmitis rate.
    Bhatt SS; Stepien KE; Joshi K
    Retina; 2011 Nov; 31(10):2032-6. PubMed ID: 21659941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. No cases of endophthalmitis after 20,293 intravitreal injections in an operating room setting.
    Brynskov T; Kemp H; Sørensen TL
    Retina; 2014 May; 34(5):951-7. PubMed ID: 24317292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endophthalmitis after injections of anti-vascular endothelial growth factor drugs.
    Stewart MW
    Retina; 2011 Nov; 31(10):1981-2. PubMed ID: 22027798
    [No Abstract]   [Full Text] [Related]  

  • 13. Intravitreal injections at the Massachusetts Eye and Ear Infirmary: analysis of treatment indications and postinjection endophthalmitis rates.
    Englander M; Chen TC; Paschalis EI; Miller JW; Kim IK
    Br J Ophthalmol; 2013 Apr; 97(4):460-5. PubMed ID: 23390167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Minimizing the endophthalmitis rate following intravitreal injections using 0.25% povidone-iodine irrigation and surgical mask.
    Shimada H; Hattori T; Mori R; Nakashizuka H; Fujita K; Yuzawa M
    Graefes Arch Clin Exp Ophthalmol; 2013 Aug; 251(8):1885-90. PubMed ID: 23389553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the incidence of endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor.
    Inoue M; Kobayakawa S; Sotozono C; Komori H; Tanaka K; Suda Y; Matsushima H; Kinoshita S; Senoo T; Tochikubo T; Kadonosono K
    Ophthalmologica; 2011; 226(3):145-50. PubMed ID: 21811052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endophthalmitis After Intravitreal Injections: Incidence, Presentation, Management, and Visual Outcome.
    Dossarps D; Bron AM; Koehrer P; Aho-Glélé LS; Creuzot-Garcher C;
    Am J Ophthalmol; 2015 Jul; 160(1):17-25.e1. PubMed ID: 25892127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. POOLED ESTIMATES OF INCIDENCE OF ENDOPHTHALMITIS AFTER INTRAVITREAL INJECTION OF ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR AGENTS WITH AND WITHOUT TOPICAL ANTIBIOTIC PROPHYLAXIS.
    Reibaldi M; Pulvirenti A; Avitabile T; Bonfiglio V; Russo A; Mariotti C; Bucolo C; Mastropasqua R; Parisi G; Longo A
    Retina; 2018 Jan; 38(1):1-11. PubMed ID: 28267115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leuconostoc as a Cause of Endophthalmitis Post-intravitreal Injection of Ranibizumab.
    Damasceno NP; Horowitz SA; Damasceno EF
    Ocul Immunol Inflamm; 2016; 24(1):118-9. PubMed ID: 24749654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of a Strict 'No-Talking' Policy During Intravitreal Injection on Post-Injection Endophthalmitis.
    Garg SJ; Dollin M; Hsu J; Storey P; Vander JF
    Ophthalmic Surg Lasers Imaging Retina; 2015; 46(10):1028-34. PubMed ID: 26599245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endophthalmitis following intravitreal anti-vascular endothelial growth factor injections for neovascular age-related macular degeneration.
    Moshfeghi AA
    Semin Ophthalmol; 2011 May; 26(3):139-48. PubMed ID: 21609227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.